A. Prado

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, The Lancet.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Percutaneous catheter-based mitral valve repair

N. Pandian, A. Gillinov, S. Oesterle, 2002 .

Abnormal Longitudinal Strain Reduction of Basal Left Ventricular Segments in Patients Recovered of COVID-19

E. Hasbani, A. Prado, J. Cotella, 2022, Journal of cardiovascular echography.

Percutaneous mitral valve repair: A feasibility study in an ovine model of acute ischemic mitral regurgitation

Natesa G Pandian, William E Cohn, W. Cohn, 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Massive Left Atrial Calcification in Late Rheumatic Heart Disease

A. Prado, J. Cotella, H. Michelena, 2022, CASE.

Aortic and Mitral Disease due to an Unusual Etiology

E. Hasbani, A. Prado, J. Cotella, 2020, Journal of cardiovascular echography.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.